Navigation Links
Conseco Completes Divestiture of Old Block of Fixed and Equity-Indexed Annuities
Date:10/12/2007

CARMEL, Ind., Oct. 12 /PRNewswire-FirstCall/ -- Conseco, Inc. (NYSE: CNO), announced that it has completed the previously announced transaction under which three insurance companies in its Conseco Insurance Group unit coinsured, with an effective date of Jan. 1, 2007, most of their older inforce equity- indexed annuity and fixed annuity business with Reassure America Life Insurance Company ("REALIC"), a subsidiary of Swiss Re Life & Health America Inc. In the transaction, REALIC paid a ceding commission of $76.5 million.

Conseco CEO Jim Prieur said, "This transaction is an important step in improving the performance of the company. It will allow us to retire four annuity administrative systems, which will further simplify our back office and reduce our operating expenses. We will consider how best to apply the proceeds from the transaction and the $175 million of capital formerly held to support these policies to increase Conseco's return on equity, including repurchases of Conseco common stock and investments in the business."

As previously reported, Conseco expects to record after-tax charges related to the transaction in the third quarter of 2007 of approximately $65 million (resulting principally from the extinguishment of the insurance intangibles associated with the business), plus the block's earnings (or minus the block's loss) between the effective date and the close of the transaction. The block's after-tax loss for the first half of 2007 was approximately $2 million, including after-tax net realized investment losses of approximately $19 million.

Conseco, Inc.'s insurance companies help protect working American families and seniors from financial adversity: Medicare supplement, long-term care, cancer, heart/stroke and accident policies protect people against major unplanned expenses; annuities and life insurance products help people plan for their financial futures. For more information, visit Conseco's web site at

SOURCE Conseco, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. iGATE Completes Phase I Testing Of Meningitis Vaccine
2. Delhi Hospital Completes 100 Liver Transplants
3. Roche Completes Acquisition of BioVeris
4. Spirulina may be the next immune boost on the block
5. Blocked viens block eye sight
6. Protein Fragments Blocking Cures Alzheimers Disease
7. Multiple Sclerosis Can Be Treated By Blocking Fat Hormone
8. Angiotensin-II-receptor blockers - Treat kidney failure
9. Re-blockage of heart arteries prevented by vitamins
10. New device for detecting artery blockages
11. Gene block keeps mice from increasing weight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...earchers who pioneered treatments which have helpe... other autoimmune diseases have been awarded the p...cal Research, announced today. , Emeritus Profes..., who have been carrying out research together at ...cted for the $100K award by an international commi...
(Date:5/12/2008)...Bermuda and COPENHAGEN, Denmark, May 12,/PRNewswir...ounced today,that the United States Food and Drug ...lication (NDA) for Taclonex Scalp(R) (calcipotrien...pical Suspension. LEO Pharma submitted,the NDA for...ex Scalp(R) is,a topical suspension containing a c...
(Date:5/12/2008)... Calif., May 12 /PRNewswire/ -- Emphasys Medical I...ENT clinical trial of the,company,s Zephyr(R) Endo...ernational Conference of the American Thoracic Soc...da., Sunday, May 18, 9:30-11:00 a.m. (ET), Metro ...osium, "Innovations in Emphysema Treatment: Lung V...
(Date:5/12/2008)...y 12 /PRNewswire-FirstCall/ -- Allied Healthcare P... its net income for the third,quarter ending March..., or,4 cents per share, to about $100,000 in the c...he third quarter increased by about $240,000 compa...r, higher material and labor costs,this fiscal yea...
Breaking Medicine News(10 mins):Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 2Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 3Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 4Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 2Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 3Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 4Health News:Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008 2Health News:Allied Healthcare Net Falls on Manufacturing Delays 2Health News:Allied Healthcare Net Falls on Manufacturing Delays 3Health News:Allied Healthcare Net Falls on Manufacturing Delays 4Health News:Allied Healthcare Net Falls on Manufacturing Delays 5
...year back, hundreds of patients and doctors were s... hurricane Katrina struck New Orleans.// On the 1-...rts from that hospital. “When you look around at ...you're in a warehouse or some kind of abandoned bu...
...t study from Stanford University has shown that th...briety.// The study appears in the September issue... Past studies had shown that besides the direct ef...do get messed up and these neuropsychological defi...
...old conjoined twins were separated after a lengthy...of the ICU.// According to their father, it is an ...errin were born in February 2002. They were conjoi...organs, including only one kidney and 2 legs. Due ...
...usets third human case of eastern equine encephali...d Middleborough boy.// According to state health ...spitalized. His parents identified him as John Fo...was included in the Massachusets’ first aerial spr...
Other Medicine News:Health News:Long term Sobriety can Reverse Effects of Alcohol Damage 2Health News:Conjoined twins doing well after separation 2
(Date:5/12/2008)...,) to acquire Iomai Corporation (,Iomai,) in a, fu...0 per share of Iomai,s common stock representing...imately USD 189 million (EUR 122 million). Acquisi...xchange for approximately 41 percent of Iomai,s c...rs for,approximately 1.7 million Intercell shares ...
(Date:5/12/2008)...wire-USNewswire/ -- The Alliance for Lupus,Researc...solution,supporting the goals and ideals of Nation...her,s Day. The resolution, introduced by Senators ...s on all Americans to take the,week of May 11th - ...n,women,s health issues, and recognizes the import...
(Date:5/12/2008)...r function like a radio dial, not an on/off,light ...isease may develop,late in life, MEMPHIS, Tenn....ldren,s,Research Hospital study shows that T cells...simple on/off switches to govern the cellular,mach...n. Rather, they,possess sophisticated molecular co...
(Date:5/12/2008)...rological recovery in severely-injured, acute ...h Cethrin, HOPKINTON, Mass., May 12 /PRNewswire-F...: ALSE ) today announced 12-month interim data,fr...oprietary recombinant,protein that is being invest...ory function after spinal cord injury, or SCI. The...
Breaking Medicine Technology:Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 1BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 2BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 3BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 4BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 5BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 6PeriCor Therapeutics Appoints K Tucker Andersen to Board of Directors 3231 1PeriCor Therapeutics Appoints K Tucker Andersen to Board of Directors 3231 2A functional immune system can be derived from embryonic stem cells preliminary study finds 11677 1A functional immune system can be derived from embryonic stem cells preliminary study finds 11677 2A functional immune system can be derived from embryonic stem cells preliminary study finds 11677 3U S Labor Department Increases Claim Assistance for Energy Workers 11674 1U S Labor Department Increases Claim Assistance for Energy Workers 11674 2
... to Help Educate on Good,Diabetes Management and H...lems, SEATTLE, April 10, 2007 /PRNewswire/ -- A fi...nd cost of type 2 diabetes,complications shows tha...ent) with type 2 diabetes have at least one of the... with the disease, and,that these health problems ...
...utilization management,programs, ST. PAUL, Minn., ...nager Prime Therapeutics (Prime) today announced t...era(R) (atomoxetine) for treating,attention defici...tudy found that children who start on Strattera we...han children who started on,stimulants. Due to the...
Other Medicine Technology:First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 2First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 3First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 4First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 5First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 6First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 7Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3
Single piece Anterior Chamber PMMA lens, AC depth: 4.9.
... Bausch & Lomb PMMA Anterior Chamber Intraocular L...hakia in patients 60 years of age or older where a...acapsular cataract extraction; or primary extracap...ral reason that the anterior chamber lens would be...
1% Sodium Hyaluronate, 10mg/mL, sterile opthalmic injection
...isc is the right viscoelastic agent for the surgeo...extracap technique. Amvisc possesses sufficient vi...ens removal. Amvisc is highly cohesive so that com... quickly accomplished. Amvisc is priced to compete...
Medicine Products: